Top Tweets for #oncoPoll
What would you do? real Case
A 58M with RRMM, prior RVD→ASCT→len maintenance, relapsed with EMD, treated with VDPACE→2nd ASCT, now on KPd for 10 years with sustained sCR and MRD negativity. Next step? #mmsm #myeloma #USMIRC #MedEd #medtwitter @US_HMC @USMIRCNEWS
Today, is there any situation or scenario you would still use methotrexate for CNS prophylaxis in lymphoma?
@OncLive @DrEdKim @NarjustFlorezMD Q. Do VEGF/PD-1 bispecific antibodies have you rethinking your frontline immunotherapy approach?
@OncLive @DrEdKim @NarjustFlorezMD #BTGLung2026
@OncLive @DrEdKim @NarjustFlorezMD @BrendonStilesMD @PercyLeeMD Poll Q3. For a patient with a solitary brain metastasis and otherwise resectable NSCLC, what is your preferred initial strategy?
#BTGLung2026 @OncLive @DrEdKim @NarjustFlorezMD @BrendonStilesMD @PercyLeeMD
Poll Q2. Does ctDNA influence your decision-making about surgery after neoadjuvant therapy?
#BTGLung2026 @OncLive @DrEdKim @NarjustFlorezMD @BrendonStilesMD @PercyLeeMD
Early-Stage NSCLC Polls!
Poll Q1. Do you consider a patient with multi-station N2 disease for definitive surgical resection?
#BTGLung2026 @OncLive @NarjustFlorezMD @DrEdKim @BrendonStilesMD @PercyLeeMD
After the 15-year SOFT/TEXT results, what is your preferred approach for high-risk premenopausal HR+/HER2− early breast cancer?
@OncoAlert #BreastCancer #bcsm #OncoPoll
After the 15-year SOFT/TEXT results, what is your preferred approach for high-risk premenopausal HR+/HER2− early breast cancer?
@OncoAlert #BreastCancer #bcsm #OncoPoll
Poll Q1. What's the biggest unmet need in SCLC care today?
#BTGLung2026 @OncLive @DrEdKim @NarjustFlorezMD @drshieldsmd
Poll Q2. Are DLL3-directed T-cell engagers changing how you sequence 2L SCLC therapy?
#BTGLung2026 @OncLive @drshieldsmd @NarjustFlorezMD @DrEdKim
IDEO Xchange: Influence of CNS protection on treatment decisions for HER2+ breast cancer
Do you proactively select HER2-targeted therapy based on CNS activity, even before CNS metastases develop?
@TumorBoardTues @CathyEngMD @IntegrityCE #PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME 🔗 https://t.co/hDrH4kl2xV
👉A patient on a zanzalintinib + atezolizumab trial asks what toxicities need close monitoring
🧐Which grade ≥3 AEs were most common in STELLAR-303❓
If gets approved, pt with advanced FGFR2-altered BTC first-line, which would you choose? @OncoAlert #oncopoll
Ya #OncoPoll
Vepdegestrant is now approved for the treatment of patients with ESR1-mutant HR+/HER2- MBC post–≥1 prior ET.
It marks the first approval for a PROTAC in oncology — though its approval and efficacy are quite overlapping with oral SERDs.
Will you use vepdegestrant in the clinic?
Bone marrow biopsy in Diffuse Large B-Cell Lymphoma
👉 What’s your current practice and why ?
@OncoAlert @Larvol
Middle aged, former tobbaco exposure, metastatic NSCLC adeno (liver and bone involvement), BRAF-V600E and PDL1 ≥ 50%, No other co-mutation. ECOG 0. Thoughts on 1L?
@lungoncdoc @ipreeshagul @dr_yakupergun @BijoyTelivala @christine_lovly @BalazsHalmosMD @christinemphmd
Do you get upfront brain MRI as part of staging in asymptomatic metastatic HER2+ or triple negative breast cancer?
#bcsm @drsarahsam @PTarantinoMD @BijoyTelivala @RenoHemonc @dr_yakupergun @hoperugo @VKaklamani @matteolambe @ErikaHamilton9 @Dr_RShatsky @sdent_cardioonc
@TumorBoardTues @riess_md @IntegrityCE @DrSanjayPopat @stephanieplsaw @StephenVLiu @LeXiuning @NarjustFlorezMD @SukiPaddaMD @JoelNealMD @Latinamd @jillfeldman4 @Exon20Group @drgandara @LeciaSequist @marinagarassino @peters_solange #PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME 🔗 https://t.co/BsND3PnJWv
🧐In the phase 2 DESTINY-Lung02 study of T-DXd for previously-treated HER2-mutant mNSCLC , what was the rate of adjudicated ILD associated with use of T-DXd 5.4 mg/kg❓
@TumorBoardTues @riess_md @IntegrityCE @DrSanjayPopat @stephanieplsaw @StephenVLiu @LeXiuning @NarjustFlorezMD @SukiPaddaMD @JoelNealMD @Latinamd @jillfeldman4 @Exon20Group @drgandara @LeciaSequist @marinagarassino @peters_solange 19/25 #TumorBoardTuesday
🤔 Would you add a PD-1 inhibitor to platinum-pemetrexed in a patient with 🫁 adenocarcinoma with a HER2 ex20ins❓
When using Capecitabine (let’s not forget… w/ voltaren gel) in Adj TNBC based off CREATE-X, do you extrapolate fixed dosing (FD) week on/week off dosing here?
@Dr_RShatsky @sdent_cardioonc @dr_yakupergun @BijoyTelivala @ErikaHamilton9 @DrSGraff #bcsm #OncTwitter @hoperugo
Most Popular Users
Elon Musk 
@elonmusk
241.1M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.2M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.4M followers
KATY PERRY
@katyperry
88.8M followers
Taylor Swift
@taylorswift13
82.7M followers
Lady Gaga
@ladygaga
74.2M followers
Virat Kohli
@imvkohli
71.6M followers
Kim Kardashian
@kimkardashian
70.3M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
64.5M followers
Bill Gates
@billgates
64.5M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
61.9M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers